science
Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reforms
The administration is moving quickly to find a successor after FDA Commissioner Marty Makary resigned on Tuesday. Officials want the next leader to rebuild trust with agency staff, emphasize food policy and continue drug-approval reforms. The search is expected to take several weeks amid a busy Senate confirmation calendar.
May 13, 2:21 PM·1m read1 source
thehindu.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The Trump administration is moving quickly to identify the next commissioner of the Food and Drug Administration after the resignation of Marty Makary on Tuesday. Administration officials are looking for someone who can rebuild trust with agency staff, focus on the agency’s food policy and continue to drive drug-approval reforms.
An official with knowledge of the process, granted anonymity to speak candidly, said leaders hope to conduct the search over the next several weeks. Despite chatter among lobbyists about potential candidates, there is currently no short list, the official said.
The process is expected to take time even with the sense of urgency.
The Senate is in session for a limited number of days in the coming weeks. Officials also need to confirm the Centers for Disease Control and Prevention nominee and the surgeon general nominee before turning full attention to the FDA role. It is possible that the former head of the FDA’s food center will remain acting commissioner through the November midterms.
The development was reported by STAT on May 13, 2026.
